On Nov 9, 2021 DNA Script closed a Grant round and raised $2,200,000 from National Human Genome Research Institute, featuring lead investors National Human Genome […]
Post-IPO Equity – AnPac Bio-Medical Science
On Nov 9, 2021 AnPac Bio-Medical Science closed a Post-IPO Equity round and raised $2,900,000 from investors, featuring lead investors . About the company: AnPac […]
Series A – Mekonos
On Nov 9, 2021 Mekonos closed a Series A round and raised $25,000,000 from Debiopharm Innovation Fund, Elementum Ventures, Fiscus Ventures, Novartis, PEAK6 Investments, Reimagined […]
Seed Round – 3Bar Biologics
On Nov 9, 2021 3Bar Biologics closed a Seed round and raised $250,000 from S2G Ventures, featuring lead investors S2G Ventures. About the company: 3Bar […]
Venture Round – Truveta
On Nov 9, 2021 Truveta closed a Venture – Series Unknown round and raised $100,000,000 from investors, featuring lead investors . About the company: Truveta […]
Series B – Arbor Biotechnologies
On Nov 9, 2021 Arbor Biotechnologies closed a Series B round and raised $215,000,000 from Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Deep Track […]
Seed Round – Ladder
On Nov 9, 2021 Ladder closed a Seed round and raised $6,500,000 from Bill Shufelt, Brett Hurt, Danny Amendola, Keller Capital, LivWell Ventures, featuring lead […]
Grant – Lifespan
On Nov 9, 2021 Lifespan closed a Grant round and raised $10,000,000 from Papitto Opportunity Connection, featuring lead investors Papitto Opportunity Connection. About the company: […]
Series B – Sirona Medical
On Nov 9, 2021 Sirona Medical closed a Series B round and raised $40,000,000 from 8VC, Avidity Partners, Global Founders Capital, GreatPoint Ventures, Rose Park […]
Series E – Color
On Nov 9, 2021 Color closed a Series E round and raised $100,000,000 from Emerson Collective, General Catalyst, Kindred Ventures, T. Rowe Price, Viking Global […]
